NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co declared a quarterly dividend on Monday, December 16th. Shareholders of record on Friday, February 14th will be paid a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date of this dividend is Thursday, February 13th. This is a boost from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) posted its earnings results on Wednesday, October, 23rd. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.43 by $0.05. The company earned $5.48 billion during the quarter, compared to the consensus estimate of $5.50 billion. Eli Lilly And Co had a net margin of 35.10% and a return on equity of 107.99%. The firm's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.39 earnings per share. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Thursday, January 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Eli Lilly And Co issued an update on its FY20 earnings guidance on Tuesday, December, 17th. The company provided EPS guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.57. The company issued revenue guidance of $23.6-24.1 billion, compared to the consensus revenue estimate of $23.46 billion.

13 brokers have issued twelve-month price objectives for Eli Lilly And Co's shares. Their forecasts range from $117.49 to $165.00. On average, they anticipate Eli Lilly And Co's stock price to reach $136.18 in the next year. This suggests that the stock has a possible downside of 3.3%. View Analyst Price Targets for Eli Lilly And Co.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Media coverage about LLY stock has trended positive recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Eli Lilly And Co earned a news sentiment score of 2.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest in December. As of December 13th, there was short interest totalling 11,580,000 shares, an increase of 9.8% from the November 28th total of 10,550,000 shares. Based on an average daily trading volume, of 3,280,000 shares, the short-interest ratio is presently 3.5 days. Approximately 1.4% of the company's shares are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AT&T (T), Intel (INTC), Verizon Communications (VZ), Bank of America (BAC), Bristol-Myers Squibb (BMY), JPMorgan Chase & Co. (JPM) and Cisco Systems (CSCO).

Eli Lilly And Co's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Lilly Endowment Inc. (11.93%), OLD National Bancorp IN (0.07%), Gateway Investment Advisers LLC (0.05%), Hexavest Inc. (0.04%), Calamos Advisors LLC (0.03%) and Country Trust Bank (0.03%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Lilly Endowment Inc., DNB Asset Management AS, State of Alaska Department of Revenue, TIAA FSB, Pennsylvania Trust Co, Gateway Investment Advisers LLC, IFM Investors Pty Ltd and Raymond James Trust N.A.. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was acquired by a variety of institutional investors in the last quarter, including Hexavest Inc., Centre Asset Management LLC, 6 Meridian, United Services Automobile Association, Donaldson Capital Management LLC, Country Trust Bank, Red Spruce Capital LLC and Boltwood Capital Management. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, Daniel Skovronsky, David A Ricks, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $140.88.

Eli Lilly And Co has a market capitalization of $135.26 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]